33. Investigating Cardiotoxicity in a 3-Drug Comparison for the Treatment of COVID19 with AnaBios's Dr. Najah Abi-Gerges

32. How Legal Drugs are Making History Faster Than Ever Before & Why Legal Drugs Agency Cares by Angela Stoyanovitch

31. Mitigating Animal Research Policy for the Cause of Biomedical & Scientific Progress with Tom Leach of Leach Policy Management, LLC

30. Mental Health as the Taboo Carotid Artery to Heart Disease with Rockwell J. Stoyanovitch

29. Overcoming Challenges in Lab Animal Science & National Meeting Updates with AALAS President Tracy Lewis Parker

28. An Alternative Narrative to Animal Research in Biotechnology & The Journey to Becoming a Lab Animal Veterinarian with Jeff Marshall

27. A CNS Update from AnaBios Corporation with Dr. Chris Mathes

26. Think Zebras, Not Horses; The Not So Rare, Rare Disease, An EDS Patient’s Journey to Diagnosis with Hannah Harrell

25. How the Pandemic has Affected the Legal Drugs Manufacturing Business with Lee Rosebush of Baker & Hostetler, LLP

24. A New Way to Conference Legal Drugs with Vivian Juter Frankel of PharmaSalon

23. Discovering a Legal Drug for COVID19 through Centivax with Sarah Ives of Distributed Bio

22. Botanical Microscopy : A Legal Drug to Replace An Illegal Drug for Research Use of 3D Tissue Clearing & Modeling

21. The Impact of Legal Drug Studies to Our Lives with Jody DeBold of JD Preclinical Solutions

20. Honoring the Role of Laboratory Animals in COVID19 Research with Dr. Cindy Buckmaster

19. Breaking the Rules for A Breakthrough Drug Against Corona Virus Outbreak

18. Building Bridges Through Toxicology with Hispanic Organization for Toxicologists with Dr. Robert Casillas and Dr. Ranulfo Lemus Olalde

17. The Umbrella of Life Sciences from Animal to Human Health with Ted Toburen

16. Surviving Cancer and Curing Disease by Converging Human Organoids via Augmented Intelligence Software with Ping Yeh, CEO & Co-Founder of StemoniX Inc.

15. Reprograming the Human Computer via Gene Therapy with Jeff Galvin, CEO of American Gene Technologies International Inc.

14. Funding the Future of Legal Drugs from the Streets of San Francisco